Ocular Therapeutix (NSDQ:OCUL) shares ticked up this morning on second-quarter results that topped revenue forecasts.
OCUL shares were up 7.6% at $11.55 just after the market opened this morning. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — remains unmoved at this early stage.
Get the full story at our sister site, Drug Delivery Business News.